Sfoglia per AUTORE
HäNEL M
Collezione AOU Alessandria
Items : 2
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network. in Lancet (London, England) / Lancet. 2024 May 25;403(10441):2293-2306. doi: 10.1016/S0140-6736(24)00184-3. Epub 2024 May 2.
2024
AOU Alessandria
AOU Alessandria
Dreyling M; Doorduijn J; Giné E; Jerkeman M; Walewski J; Hutchings M; Mey U; Riise J; Trneny M; Vergote V; Shpilberg O; Gomes da Silva M; Leppä S; Jiang L; Stilgenbauer S; Kerkhoff A; Jachimowicz RD; Celli M; Hess G; Arcaini L; Visco C; van Meerten T; Wirths S; Zinzani PL; Novak U; Herhaus P; Benedetti F; Sonnevi K; Hanoun C; et alii...
Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Mar;57(3):499-501. doi: 10.1038/s41409-021-01560-y. Epub 2022 Jan 10.
2022
AOU Alessandria
AOU Alessandria
Vincent L; Gras L; Ceballos P; Finke J; Passweg J; Harel S; Rosinol L; Minnema M; Teipel R; van Doesum J; Hänel M; Lenain P; Botella-Garcia C; Koenecke C; Ducastelle S; Sanz J; Schroyens W; Zuckerman T; Monaco F; Koster L; de Wreede L; Hayden PJ; Schönland S; Yakoub-Agha I; Beksac M;